BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 7,500.00
-160.00 (-2.09%)
Aug 12, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 243.95 billion as of August 11, 2026. Its market cap has decreased by -51.76% in one year.
Market Cap
243.95B
Enterprise Value
327.55B
Revenue
164.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,500.00
ChartMarket Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 243.95B, an increase of 864.78%. That is a compound annual growth rate of 9.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 243.95B | -48.87% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 364.46B |
| Proteina | 345.40B |
| SillaJen | 320.75B |
| GC Cell | 227.06B |
| HLB Therapeutics | 218.00B |
| EASY BIO,Inc. | 214.70B |
| Bioneer | 191.25B |
| JETEMA, | 169.28B |